Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Status |
|---|---|---|---|
| 1 | Not yet disclosed by govt. Qualified Make: GSK
Model: DPI UMECLIDINIUM (62.5 MCG) , VILANTEROL (25 MCG)
Title: DPI UMECLIDINIUM (62.5 MCG) , VILANTEROL (25 MCG) , FLUTICASONE (100MCG) (ICS+ LABA+ LAMA) | Make: GSK
Model: DPI UMECLIDINIUM (62.5 MCG) , VILANTEROL (25 MCG)
Title: DPI UMECLIDINIUM (62.5 MCG) , VILANTEROL (25 MCG) , FLUTICASONE (100MCG) (ICS+ LABA+ LAMA) | Qualified MII |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Jan 2024, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DPI UMECLIDINIUM (62.5 MCG)
VILANTEROL (25 MCG)
FLUTICASONE (100MCG) (ICS+ LABA+ LAMA) (Q3)
5614836
GEM/2023/B/4225704
Two Packet Bid
DPI UMECLIDINIUM (62.5 MCG) , VILANTEROL (25 MCG) , FLUTICASONE (100MCG) (ICS+ LABA+ LAMA)
15 days
Jharkhand; Ranchi
Total value wise evaluation
PRODUCT_CUSTOM
6 documents required · 6 mandatory
3 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| DPI UMECLIDINIUM (62.5 MCG) | - | - | - |
| VILANTEROL (25 MCG) | - | - | - |
| FLUTICASONE (100MCG) (ICS+ LABA+ LAMA) (Q3) | - | - | - |
Exempted
1 Jan 2024
20 Dec 2023
1 Jan 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5614836.pdf
GEM_BID
new_microsoft_word_document_2023-11-15-14-20-07_1997e9e3874e448861900b8a9ddbaf88.pdf
SPECIFICATION
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .